Blood bank management of sickle cell patients at comprehensive sickle cell centers

Transfusion

Volumn 47, Issue 11, 2007, Pages 2089-2097

  Afenyi Annan, Araba ^a   Willis, Monte S ^b   Konrad, Thomas R ^b   Lottenberg, Richard ^b  

^a UNIVERSITY OF NORTH CAROLINA HOSPITALS   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ADMINISTRATIVE PERSONNEL; ADOLESCENT; ARTICLE; BLOOD BANK; BLOOD TRANSFUSION; BLOOD TRANSFUSION REACTION; CHILD; CLINICAL ARTICLE; CLINICAL PRACTICE; CONTROLLED STUDY; ERYTHROCYTE; HEALTH CENTER; HEALTH PROGRAM; HEALTH SURVEY; HOSPITAL ADMINISTRATOR; HUMAN; MORTALITY; PATIENT CARE; PHENOTYPE; SICKLE CELL;

ANEMIA, SICKLE CELL; BLOOD BANKS; BLOOD TRANSFUSION; CONSENSUS; CROSS-SECTIONAL STUDIES; DATA COLLECTION; DISEASE MANAGEMENT; HEALTH FACILITIES; HUMANS; REFERENCE STANDARDS;

EID: 35448960846     PISSN: 00411132     EISSN: 15372995     Source Type: Journal    
DOI: 10.1111/j.1537-2995.2007.01434.x     Document Type: Article

References (47)

1. National Comprehensive Sickle Cell Centers [homepage on the Internet]. Bethesda : U.S. Department of Health and Human Services, National Institues of Health, National Heart Lung and Blood Institute c2007 [accessed 2006 Dec 1]. Available from: http://www.sicklecell-info.org/Intro.html
2. Leikin SL, Gallagher D, Kinney TR, Sloane D, Klug P, Rida W. Mortality in children and adolescents with sickle cell disease. Cooperative Study of Sickle Cell Disease. Pediatrics 1989 84 : 500 8.
3. West MS, Wethers D, Smith J, Steinberg M. Laboratory profile of sickle cell disease: a cross-sectional analysis. The Cooperative Study of Sickle Cell Disease. J Clin Epidemiol 1992 45 : 893 909.
4. Castro O, Brambilla DJ, Thorington B, Reindorf CA, Scott RB, Gillette P, Vera JC, Levy PS. The acute chest syndrome in sickle cell disease: incidence and risk factors. The Cooperative Study of Sickle Cell Disease. Blood 1994 84 : 643 9.
5. Smith JA, Espeland M, Bellevue R, Bonds D, Brown AK, Koshy M. Pregnancy in sickle cell disease: experience of the Cooperative Study of Sickle Cell Disease. Obstet Gynecol 1996 87 : 199 204.
6. Platt OS, Brambilla DJ, Rosse WF, Milner PF, Castro O, Steinberg MH, Klug PP. Mortality in sickle cell disease: life expectancy and risk factors for early death. N Engl J Med 1994 330 : 1639 44.
7. Gaston MH, Verter JI, Woods G, Pegelow C, Kelleher J, Presbury G, Zarkowsky H, Vichinsky E, Iyer R, Lobel JS, et al. Prophylaxis with oral penicillin in children with sickle cell anemia: a randomized trial. N Engl J Med 1986 314 : 1593 9.
8. Falletta JM, Woods GM, Verter JI, Buchanan GR, Pegelow CH, Iyer RV, Miller ST, Holbrook CT, Kinney TR, Vichinsky E, et al. Discontinuing penicillin prophylaxis in children with sickle cell anemia: Prophylactic Penicillin Study II. J Pediatr 1995 127 : 685 90.
9. Charache S, Dover GJ, Moore RD, Eckert S, Ballas SK, Koshy M, Milner PF, Orringer EP, Phillips G, Platt OS, et al. Hydroxyurea: effects on hemoglobin F production in patients with sickle cell anemia. Blood 1992 79 : 2555 65.
10. Charache S, Terrin ML, Moore RD, Dover GJ, Barton FB, Eckert SV, McMahon RP, Bonds DR. Effect of hydroxyurea on the frequency of painful crises in sickle cell anemia. Investigators of the Multicenter Study of Hydroxyurea in Sickle Cell Anemia. N Engl J Med 1995 332 : 1317 22.
11. Steinberg MH, Barton F, Castro O, Pegelow CH, Ballas SK, Kutlar A, Orringer E, Bellevue R, Olivieri N, Eckman J, Varma M, Ramirez G, Adler B, Smith W, Carlos T, Ataga K, DeCastro L, Bigelow C, Saunthararajah Y, Telfer M, Vichinsky E, Claster S, Shurin S, Bridges K, Waclawiw M, Bonds D, Terrin M. Effect of hydroxyurea on mortality and morbidity in adult sickle cell anemia: risks and benefits up to 9 years of treatment. JAMA 2003 289 : 1645 51.
12. Kinney TR, Helms RW, O'Branski EE, Ohene-Frempong K, Wang W, Daeschner C, Vichinsky E, Redding-Lallinger R, Gee B, Platt OS, Ware RE. Safety of hydroxyurea in children with sickle cell anemia: results of the HUG-KIDS study, a phase I/II trial. Pediatric Hydroxyurea Group. Blood 1999 94 : 1550 4.
13. Adams RJ, McKie VC, Hsu L, Files B, Vichinsky E, Pegelow C, Abboud M, Gallagher D, Kutlar A, Nichols FT, Bonds DR, Brambilla D. Prevention of a first stroke by transfusions in children with sickle cell anemia and abnormal results on transcranial Doppler ultrasonography. N Engl J Med 1998 339 : 5 11.
14. Vichinsky EP, Haberkern CM, Neumayr L, Earles AN, Black D, Koshy M, Pegelow C, Abboud M, Ohene-Frempong K, Iyer RV. A comparison of conservative and aggressive transfusion regimens in the perioperative management of sickle cell disease. The Preoperative Transfusion in Sickle Cell Disease Study Group. N Engl J Med 1995 333 : 206 13.
15. Reed W, Vichinsky EP. Transfusion therapy: a coming-of-age treatment for patients with sickle cell disease. J Pediatr Hematol Oncol 2001 23 : 197 202.
16. Thame JR, Hambleton IR, Serjeant GR. RBC transfusion in sickle cell anemia (HbSS): experience from the Jamaican Cohort Study. Transfusion 2001 41 : 596 601.
17. Rosse WF, Gallagher D, Kinney TR, Castro O, Dosik H, Moohr J, Wang W, Levy PS. Transfusion and alloimmunization in sickle cell disease. The Cooperative Study of Sickle Cell Disease. Blood 1990 76 : 1431 7.
18. Sarnaik S, Schornack J, Lusher JM. The incidence of development of irregular red cell antibodies in patients with sickle cell anemia. Transfusion 1986 26 : 249 52.
19. Friedman DF, Lukas MB, Jawad A, Larson PJ, Ohene-Frempong K, Manno CS. Alloimmunization to platelets in heavily transfused patients with sickle cell disease. Blood 1996 88 : 3216 22.
20. Adams RJ, Brambilla D. Discontinuing prophylactic transfusions used to prevent stroke in sickle cell disease. N Engl J Med 2005 353 : 2769 78.
21. Wang WC, Kovnar EH, Tonkin IL, Mulhern RK, Langston JW, Day SW, Schell MJ, Wilimas JA. High risk of recurrent stroke after discontinuance of five to twelve years of transfusion therapy in patients with sickle cell disease. J Pediatr 1991 118 : 377 82.
22. Vichinsky EP. Current issues with blood transfusions in sickle cell disease. Semin Hematol 2001 38 (1 Suppl 1 14 22.
23. Telen MJ. Principles and problems of transfusion in sickle cell disease. Semin Hematol 2001 38 : 315 23.
24. NIH, National Heart, Lung, and Blood Institute, Division of Blood Diseases and Resources. The management of sickle cell disease. 4th ed. Bethesda : National Institutes of Health 2002.
25. Rosse WF, Telen MJ, Ware RE. Transfusion support for patients with sickle cell disease. Bethesda : American Association of Blood Banks 1998.
26. Vichinsky E. Consensus document for transfusion-related iron overload. Semin Hematol 2001 38 (1 Suppl 1 2 4.
27. Afenyi-Annan A, Brecher ME. Pre-transfusion phenotype matching for sickle cell disease patients. Transfusion 2004 44 : 619 20.
28. Osby M, Shulman IA. Phenotype matching of donor red blood cell units for nonalloimmunized sickle cell disease patients. a survey of 1182 North American laboratories. Arch Pathol Lab Med 2005 129 : 190 3.
29. Vichinsky EP, Luban NL, Wright E, Olivieri N, Driscoll C, Pegelow CH, Adams RJ Stroke Prevention Trail in Sickle Cell Anemia. Prospective RBC phenotype matching in a stroke-prevention trial in sickle cell anemia: a multicenter transfusion trial. Transfusion 2001 41 : 1086 92.
30. Vichinsky EP, Earles A, Johnson RA, Hoag MS, Williams A, Lubin B. Alloimmunization in sickle cell anemia and transfusion of racially unmatched blood. N Engl J Med 1990 322 : 1617 21.
31. Brand A. Passenger leukocytes, cytokines, and transfusion reactions. N Engl J Med 1994 331 : 670 1.
32. Sosler SD, Jilly BJ, Saporito C, Koshy M. A simple, practical model for reducing alloimmunization in patients with sickle cell disease. Am J Hematol 1993 43 : 103 6.
33. Castro O, Sandler SG, Houston-Yu P, Rana S. Predicting the effect of transfusing only phenotype-matched RBCs to patients with sickle cell disease: theoretical and practical implications. Transfusion 2002 42 : 684 90.
34. Isaak EJ, LeChien B, Lindsey T, Debaun MR. The Charles Drew program in Missouri: a description of a partnership among a blood center and several hospitals to address the care of patients with sickle cell disease. Immunohematology 2006 22 : 112 6.
35. Haberkern CM, Neumayr LD, Orringer EP, et al. Cholecystectomy in sickle cell anemia patients: perioperative outcome of 364 cases from the National Preoperative Transfusion Study. Preoperative Transfusion in Sickle Cell Disease Study Group. Blood 1997 89 : 1533 42.
36. Koshy M, Weiner SJ, Miller ST, Sleeper LA, Vichinsky E, Brown AK, Khakoo Y, Kinney TR. Surgery and anesthesia in sickle cell disease. Cooperative Study of Sickle Cell Diseases. Blood 1995 86 : 3676 84.
37. Bischoff RJ, Williamson A 3rd., Dalali MJ, Rice JC, Kerstein MD. Assessment of the use of transfusion therapy perioperatively in patients with sickle cell hemoglobinopathies. Ann Surg 1988 207 : 434 8.
38. Riddington C, Williamson L. Preoperative blood transfusions for sickle cell disease. Cochrane Database Syst Rev 2001 3 CD003149.
39. Griffin TC, Buchanan GR. Elective surgery in children with sickle cell disease without preoperative blood transfusion. J Pediatr Surg 1993 28 : 681 5.
40. Suell MN, Horton TM, Dishop MK, Mahoney DH, Olutoye OO, Mueller BU. Outcomes for children with gallbladder abnormalities and sickle cell disease. J Pediatr 2004 145 : 617 21.
41. Leff DR, Kaura T, Agarwal T, Davies SC, Howard J, Chang AC. A nontransfusional perioperative management regimen for patients with sickle cell disease undergoing laparoscopic cholecystectomy. Surg Endosc 2006 21 : 1117 21.
42. Buck J, Casbard A, Llewelyn C, Johnson T, Davies S, Williamson L. Preoperative transfusion in sickle cell disease: a survey of practice in England [published erratum appears in Eur J Haematol 2005;75:271]. Eur J Haematol 2005 75 : 14 21.
43. Cox JV, Steane E, Cunningham G, Frenkel EP. Risk of alloimmunization and delayed hemolytic transfusion reactions in patients with sickle cell disease. Arch Intern Med 1988 148 : 2485 9.
44. Talano JA, Hillery CA, Gottschall JL, Baylerian DM, Scott JP. Delayed hemolytic transfusion reaction/hyperhemolysis syndrome in children with sickle cell disease. Pediatrics 2003 111 (6 Pt 1 e661 5.
45. King KE, Shirey RS, Lankiewicz MW, Young-Ramsaran J, Ness PM. Delayed hemolytic transfusion reactions in sickle cell disease: simultaneous destruction of recipients' red cells. Transfusion 1997 37 : 376 81.
46. Rosse WF, Narla M, Petz LD, Steinberg MH. New Views of Sickle Cell Disease Pathophysiology and Treatment. Hematology (Am Soc Hematol Educ Program) 2000 : 2 17.
47. Afenyi-Annan A, Konrad TR, Lottenberg R. Blood bank practices for sickle cell patients in North Carolina. Transfusion 2004 44 (9 Suppl 135.